Evidence map›Paper›PMID 42122273›Full record

ArticleCancers2026

T-Cell Clonal Expansion in Peripheral Blood Following Interventional Radiology Procedures for Metastatic Liver Cancer.

Chenyang Zhan, Anita Karimi, Leila Haghani, Brett Marinelli, Wei Tian, Etay Ziv, Hooman Yarmohammadi, Erica S Alexander, Vlasios S Sotirchos, Ken Zhao and 4 more

Abstract read
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Chenyang ZhanInterventional Radiology Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.
Anita KarimiInterventional Radiology Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.ORCID 0000-0002-1815-3799
Leila HaghaniInterventional Radiology Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.ORCID 0000-0001-7156-4004
Brett MarinelliInterventional Radiology Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.
Wei TianInterventional Radiology Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.
Etay ZivInterventional Radiology Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.
Hooman YarmohammadiInterventional Radiology Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.
Erica S AlexanderInterventional Radiology Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.
Vlasios S SotirchosInterventional Radiology Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.ORCID 0000-0001-7278-1369
Ken ZhaoInterventional Radiology Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.
James W SmithyDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.ORCID 0000-0003-3126-1193
Alexander N ShoushtariDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.ORCID 0000-0002-8065-4412
David A ScheinbergCenter for Experimental Therapeutics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Joseph P ErinjeriInterventional Radiology Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.ORCID 0000-0003-1876-727X

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748Society for Interventional Oncology Society for Interventional Oncology (SIO) Interventional Oncology / Immuno-oncology grant
6 · The paper itself

Abstract

backgroundInterventional radiology (IR) procedures may induce anti-tumor immune responses, with subsequent clonal expansion of specific T-cells recognizing tumor antigens. This exploratory study aims to investigate the clonal expansion of T-cells in the peripheral blood after interventional radiology procedures for metastatic liver cancer.

methodsThis prospective study included 16 patients with metastatic liver cancer undergoing IR procedures (13 embolizations and 3 ablations). Biopsy samples were collected prior to the procedure, and peripheral blood samples were obtained both pre- and post-procedure. Bulk T-cell receptor (TCR) sequencing was conducted to assess T-cell clonality dynamics and to evaluate the impact of procedures on the T-cell repertoire.

resultsThe overall clonality of the T-cell repertoire in the peripheral blood did not demonstrate significant variations following IR procedures (

conclusionsIR procedures do not alter the overall clonality of the T-cell repertoire but may promote the expansion of a limited number of clonotypes. This study demonstrates that it is feasible to detect and longitudinally track expanding T-cell clonotypes following IR liver-directed therapy. Further studies are needed to determine whether these expanding clonotypes contribute to systemic anti-tumor immunity.

Indexed as

ablationembolizationmetastatic liver cancerT-cell clonalityTCR sequencing

Identifiers

PMID42122273
PMCPMC13162843

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.